NOVA2-mediated RNA regulation is required for axonal pathfinding during development

  1. Yuhki Saito
  2. Soledad Miranda-Rottmann
  3. Matteo Ruggiu
  4. Christopher Y Park
  5. John J Fak
  6. Ru Zhong
  7. Jeremy S Duncan
  8. Brian A Fabella
  9. Harald J Junge
  10. Zhe Chen
  11. Roberto Araya
  12. Bernd Fritzsch
  13. A J Hudspeth
  14. Robert B Darnell  Is a corresponding author
  1. Howard Hughes Medical Institute, The Rockefeller University, United States
  2. New York Genome Center, United States
  3. University of Iowa, United States
  4. University of Colorado, Boulder, United States
  5. University of Montreal, Canada

Abstract

The neuron specific RNA-binding proteins NOVA1 and NOVA2 are highly homologous alternative splicing regulators. NOVA proteins regulate at least 700 alternative splicing events in vivo, yet relatively little is known about the biologic consequences of NOVA action and in particular about functional differences between NOVA1 and NOVA2. Transcriptome-wide searches for isoform-specific functions, using NOVA1 and NOVA2 specific HITS-CLIP and RNA-seq data from mouse cortex lacking either NOVA isoform, reveals that NOVA2 uniquely regulates alternative splicing events of a series of axon guidance related genes during cortical development. Corresponding axonal pathfinding defects were specific to NOVA2 deficiency: Nova2-/- but not Nova1-/- mice had agenesis of the corpus callosum, and axonal outgrowth defects specific to ventral motoneuron axons and efferent innervation of the cochlea. Thus we have discovered that NOVA2 uniquely regulates alternative splicing of a coordinate set of transcripts encoding key components in cortical, brainstem and spinal axon guidance/outgrowth pathways during neural differentiation, with severe functional consequences in vivo.

Article and author information

Author details

  1. Yuhki Saito

    Laboratory of Molecular Neuro-Oncology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Soledad Miranda-Rottmann

    Laboratory of Molecular Neuro-Oncology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Matteo Ruggiu

    Laboratory of Molecular Neuro-Oncology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Christopher Y Park

    New York Genome Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. John J Fak

    Laboratory of Molecular Neuro-Oncology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Ru Zhong

    Laboratory of Molecular Neuro-oncology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Jeremy S Duncan

    Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Brian A Fabella

    Laboratory of Sensory Neuroscience, Howard Hughes Medical Institute, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Harald J Junge

    Department of MCDB, University of Colorado, Boulder, Boulder, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Zhe Chen

    Department of MCDB, University of Colorado, Boulder, Boulder, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Roberto Araya

    Department of Neurosciences, Faculty of Medicine, University of Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  12. Bernd Fritzsch

    Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. A J Hudspeth

    Laboratory of Sensory Neuroscience, Howard Hughes Medical Institute, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Robert B Darnell

    Laboratory of Molecular Neuro-Oncology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States
    For correspondence
    darnelr@rockefeller.edu
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: This studies were performed in compliance with protocols (#14678 and #07069) approved by the Institutional Animal Care and Use Committee (IACUC) of the Rockefeller University or with protocols (13-185 and 15-002) approved by the Comité de déontologie de l'expérimentation sur les animaux (CDEA) of the Univeristy of Montreal.

Copyright

© 2016, Saito et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 100
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yuhki Saito
  2. Soledad Miranda-Rottmann
  3. Matteo Ruggiu
  4. Christopher Y Park
  5. John J Fak
  6. Ru Zhong
  7. Jeremy S Duncan
  8. Brian A Fabella
  9. Harald J Junge
  10. Zhe Chen
  11. Roberto Araya
  12. Bernd Fritzsch
  13. A J Hudspeth
  14. Robert B Darnell
(2016)
NOVA2-mediated RNA regulation is required for axonal pathfinding during development
eLife 5:e14371.
https://doi.org/10.7554/eLife.14371

Share this article

https://doi.org/10.7554/eLife.14371

Further reading

    1. Neuroscience
    Brian C Ruyle, Sarah Masud ... Jose A Morón
    Research Article

    Millions of Americans suffering from Opioid Use Disorders face a high risk of fatal overdose due to opioid-induced respiratory depression (OIRD). Fentanyl, a powerful synthetic opioid, is a major contributor to the rising rates of overdose deaths. Reversing fentanyl overdoses has proved challenging due to its high potency and the rapid onset of OIRD. We assessed the contributions of central and peripheral mu opioid receptors (MORs) in mediating fentanyl-induced physiological responses. The peripherally restricted MOR antagonist naloxone methiodide (NLXM) both prevented and reversed OIRD to a degree comparable to that of naloxone (NLX), indicating substantial involvement of peripheral MORs to OIRD. Interestingly, NLXM-mediated OIRD reversal did not produce aversive behaviors observed after NLX. We show that neurons in the nucleus of the solitary tract (nTS), the first central synapse of peripheral afferents, exhibit a biphasic activity profile following fentanyl exposure. NLXM pretreatment attenuates this activity, suggesting that these responses are mediated by peripheral MORs. Together, these findings establish a critical role for peripheral MORs, including ascending inputs to the nTS, as sites of dysfunction during OIRD. Furthermore, selective peripheral MOR antagonism could be a promising therapeutic strategy for managing OIRD by sparing CNS-driven acute opioid-associated withdrawal and aversion observed after NLX.

    1. Neuroscience
    Yi-Yun Ho, Qiuwei Yang ... Melissa R Warden
    Research Article

    The infralimbic cortex (IL) is essential for flexible behavioral responses to threatening environmental events. Reactive behaviors such as freezing or flight are adaptive in some contexts, but in others a strategic avoidance behavior may be more advantageous. IL has been implicated in avoidance, but the contribution of distinct IL neural subtypes with differing molecular identities and wiring patterns is poorly understood. Here, we study IL parvalbumin (PV) interneurons in mice as they engage in active avoidance behavior, a behavior in which mice must suppress freezing in order to move to safety. We find that activity in inhibitory PV neurons increases during movement to avoid the shock in this behavioral paradigm, and that PV activity during movement emerges after mice have experienced a single shock, prior to learning avoidance. PV neural activity does not change during movement toward cued rewards or during general locomotion in the open field, behavioral paradigms where freezing does not need to be suppressed to enable movement. Optogenetic suppression of PV neurons increases the duration of freezing and delays the onset of avoidance behavior, but does not affect movement toward rewards or general locomotion. These data provide evidence that IL PV neurons support strategic avoidance behavior by suppressing freezing.